Which has preferable earnings & valuation, ABT or DXCM?

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Abbott Laboratories $44.33B 3.69 $6.52B $3.57 26.32 DexCom $4.66B 6.20 $836.30M $2.34 32.03

Is ABT or DXCM more profitable?

DexCom has a net margin of 19.31% compared to Abbott Laboratories' net margin of 13.90%. DexCom's return on equity of 33.33% beat Abbott Laboratories' return on equity. Company Net Margins Return on Equity Return on Assets Abbott Laboratories 13.90% 17.62% 10.01% DexCom 19.31% 33.33% 13.19%

Does the media refer more to ABT or DXCM?

In the previous week, Abbott Laboratories had 6 more articles in the media than DexCom. MarketBeat recorded 27 mentions for Abbott Laboratories and 21 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.38 beat DexCom's score of 0.82 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 21 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 13 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor ISRG or ABT?

In the previous week, Intuitive Surgical had 3 more articles in the media than Abbott Laboratories. MarketBeat recorded 30 mentions for Intuitive Surgical and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat Intuitive Surgical's score of 1.02 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 18 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 21 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ABT or TSLA?

In the previous week, Tesla had 206 more articles in the media than Abbott Laboratories. MarketBeat recorded 233 mentions for Tesla and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat Tesla's score of 0.61 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 21 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Tesla 103 Very Positive mention(s) 36 Positive mention(s) 51 Neutral mention(s) 22 Negative mention(s) 8 Very Negative mention(s) Positive

Is ABT or ABBV more profitable?

Abbott Laboratories has a net margin of 13.90% compared to AbbVie's net margin of 5.79%. Abbott Laboratories' return on equity of 17.62% beat AbbVie's return on equity. Company Net Margins Return on Equity Return on Assets Abbott Laboratories 13.90% 17.62% 10.01% AbbVie 5.79% -576.45% 13.39%

Does the media refer more to ABT or ABBV?

In the previous week, AbbVie had 13 more articles in the media than Abbott Laboratories. MarketBeat recorded 40 mentions for AbbVie and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat AbbVie's score of 0.87 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 21 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AbbVie 18 Very Positive mention(s) 5 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ABT or BSX?

In the previous week, Abbott Laboratories had 2 more articles in the media than Boston Scientific. MarketBeat recorded 27 mentions for Abbott Laboratories and 25 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.38 beat Boston Scientific's score of 1.03 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 21 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 15 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Abbott Laboratories (ABT) Competitors

$93.98 -0.43 (-0.45%)

Closing price 07/10/2026 03:59 PM Eastern

Extended Trading

$94.06 +0.08 (+0.09%)

As of 07/10/2026 07:52 PM Eastern

Compare

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

Should you buy Abbott Laboratories stock or one of its competitors? MarketBeat compares Abbott Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Abbott Laboratories include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), and Boston Scientific (BSX).

How does Abbott Laboratories compare to DexCom?

Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

Abbott Laboratories currently has a consensus target price of $118.42, indicating a potential upside of 26.01%. DexCom has a consensus target price of $84.88, indicating a potential upside of 13.23%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Abbott Laboratories is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.93
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

Abbott Laboratories has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, DexCom has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

DexCom has a net margin of 19.31% compared to Abbott Laboratories' net margin of 13.90%. DexCom's return on equity of 33.33% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
DexCom	19.31%	33.33%	13.19%

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.69	$6.52B	$3.57	26.32
DexCom	$4.66B	6.20	$836.30M	$2.34	32.03

In the previous week, Abbott Laboratories had 6 more articles in the media than DexCom. MarketBeat recorded 27 mentions for Abbott Laboratories and 21 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.38 beat DexCom's score of 0.82 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	21 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	13 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Abbott Laboratories beats DexCom on 9 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.31	$2.86B	$8.25	49.31
Abbott Laboratories	$44.33B	3.69	$6.52B	$3.57	26.32

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.6% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Intuitive Surgical has a net margin of 28.15% compared to Abbott Laboratories' net margin of 13.90%. Abbott Laboratories' return on equity of 17.62% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Abbott Laboratories	13.90%	17.62%	10.01%

In the previous week, Intuitive Surgical had 3 more articles in the media than Abbott Laboratories. MarketBeat recorded 30 mentions for Intuitive Surgical and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat Intuitive Surgical's score of 1.02 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	18 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	21 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Intuitive Surgical has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Intuitive Surgical currently has a consensus price target of $569.20, indicating a potential upside of 39.93%. Abbott Laboratories has a consensus price target of $118.42, indicating a potential upside of 26.01%. Given Intuitive Surgical's higher possible upside, research analysts clearly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.71
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.93

Summary

Intuitive Surgical beats Abbott Laboratories on 10 of the 16 factors compared between the two stocks.

How does Abbott Laboratories compare to Tesla?

Abbott Laboratories (NYSE:ABT) and Tesla (NASDAQ:TSLA) are related large-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Abbott Laboratories presently has a consensus price target of $118.42, suggesting a potential upside of 26.01%. Tesla has a consensus price target of $406.87, suggesting a potential downside of 0.22%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities analysts clearly believe Abbott Laboratories is more favorable than Tesla.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.93
Tesla	4 Sell rating(s)	21 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.37

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 66.2% of Tesla shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 19.9% of Tesla shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Abbott Laboratories has a net margin of 13.90% compared to Tesla's net margin of 3.95%. Abbott Laboratories' return on equity of 17.62% beat Tesla's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Tesla	3.95%	4.89%	2.93%

In the previous week, Tesla had 206 more articles in the media than Abbott Laboratories. MarketBeat recorded 233 mentions for Tesla and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat Tesla's score of 0.61 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	21 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tesla	103 Very Positive mention(s)	36 Positive mention(s)	51 Neutral mention(s)	22 Negative mention(s)	8 Very Negative mention(s)	Positive

Abbott Laboratories has higher earnings, but lower revenue than Tesla. Abbott Laboratories is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.69	$6.52B	$3.57	26.32
Tesla	$94.83B	16.15	$3.79B	$1.09	374.09

Abbott Laboratories has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Tesla has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market.

Summary

Abbott Laboratories beats Tesla on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to AbbVie?

Abbott Laboratories (NYSE:ABT) and AbbVie (NYSE:ABBV) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Abbott Laboratories has a net margin of 13.90% compared to AbbVie's net margin of 5.79%. Abbott Laboratories' return on equity of 17.62% beat AbbVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
AbbVie	5.79%	-576.45%	13.39%

Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.7%. AbbVie pays an annual dividend of $6.92 per share and has a dividend yield of 2.8%. Abbott Laboratories pays out 70.6% of its earnings in the form of a dividend. AbbVie pays out 340.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 54 consecutive years and AbbVie has raised its dividend for 53 consecutive years.

In the previous week, AbbVie had 13 more articles in the media than Abbott Laboratories. MarketBeat recorded 40 mentions for AbbVie and 27 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.38 beat AbbVie's score of 0.87 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	21 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
AbbVie	18 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 70.2% of AbbVie shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.1% of AbbVie shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Abbott Laboratories currently has a consensus price target of $118.42, indicating a potential upside of 26.01%. AbbVie has a consensus price target of $262.81, indicating a potential upside of 5.97%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, research analysts plainly believe Abbott Laboratories is more favorable than AbbVie.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.93
AbbVie	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.84

Abbott Laboratories has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, AbbVie has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market.

Abbott Laboratories has higher earnings, but lower revenue than AbbVie. Abbott Laboratories is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.69	$6.52B	$3.57	26.32
AbbVie	$61.16B	7.16	$4.23B	$2.03	122.17

Summary

Abbott Laboratories beats AbbVie on 14 of the 20 factors compared between the two stocks.

How does Abbott Laboratories compare to Boston Scientific?

Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Boston Scientific has a net margin of 17.29% compared to Abbott Laboratories' net margin of 13.90%. Boston Scientific's return on equity of 19.17% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.90%	17.62%	10.01%
Boston Scientific	17.29%	19.17%	10.77%

Abbott Laboratories currently has a consensus target price of $118.42, suggesting a potential upside of 26.01%. Boston Scientific has a consensus target price of $81.32, suggesting a potential upside of 82.03%. Given Boston Scientific's higher probable upside, analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.93
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.77

In the previous week, Abbott Laboratories had 2 more articles in the media than Boston Scientific. MarketBeat recorded 27 mentions for Abbott Laboratories and 25 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.38 beat Boston Scientific's score of 1.03 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	21 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	15 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Abbott Laboratories has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.69	$6.52B	$3.57	26.32
Boston Scientific	$20.07B	3.31	$2.90B	$2.39	18.69

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Abbott Laboratories beats Boston Scientific on 11 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABT vs. The Competition

Export

Metric	Abbott Laboratories	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$164.43B	$8.80B	$7.12B	$23.43B
Dividend Yield	2.67%	2.52%	2.68%	4.04%
P/E Ratio	26.32	16.12	27.22	31.27
Price / Sales	3.69	7.15	590.16	20.39
Price / Cash	13.50	18.15	49.34	25.05
Price / Book	3.10	3.60	10.90	4.77
Net Income	$6.52B	$228.19M	$3.57B	$1.07B
7 Day Performance	-1.34%	-0.18%	-0.25%	-0.50%
1 Month Performance	4.83%	-0.41%	5.77%	2.09%
1 Year Performance	-28.78%	-5.19%	28.14%	16.03%

Abbott Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABT Abbott Laboratories	4.9921 of 5 stars	$93.98 -0.5%	$118.42 +26.0%	-29.7%	$164.43B	$44.33B	26.32	115,000	Positive News Upcoming Earnings Analyst Upgrade
DXCM DexCom	4.2489 of 5 stars	$72.38 +1.6%	$84.88 +17.3%	-12.3%	$27.49B	$4.66B	30.93	11,000	Analyst Upgrade Insider Trade
ISRG Intuitive Surgical	4.697 of 5 stars	$432.83 +1.6%	$571.33 +32.0%	-22.7%	$150.88B	$10.06B	52.46	17,021	Trending News Upcoming Earnings Analyst Upgrade
TSLA Tesla	3.0538 of 5 stars	$419.77 +6.7%	$403.92 -3.8%	+31.6%	$1.48T	$94.83B	385.11	134,785	Trending News Analyst Forecast Analyst Revision
ABBV AbbVie	4.7491 of 5 stars	$254.77 -2.4%	$256.67 +0.7%	+27.2%	$461.26B	$61.16B	125.50	57,000	Trending News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ABT) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Summary

How does Abbott Laboratories compare to Tesla?

Summary

How does Abbott Laboratories compare to AbbVie?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Do analysts prefer ABT or DXCM?

Which has more volatility and risk, ABT or DXCM?

Is ABT or DXCM more profitable?

Which has preferable earnings & valuation, ABT or DXCM?

Does the media refer more to ABT or DXCM?

Do institutionals and insiders have more ownership in ABT or DXCM?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Which has higher valuation & earnings, ISRG or ABT?

Do institutionals & insiders believe in ISRG or ABT?

Is ISRG or ABT more profitable?

Does the media favor ISRG or ABT?

Which has more risk & volatility, ISRG or ABT?

Do analysts prefer ISRG or ABT?

Summary

How does Abbott Laboratories compare to Tesla?

Do analysts rate ABT or TSLA?

Do institutionals and insiders hold more shares of ABT or TSLA?

Is ABT or TSLA more profitable?

Does the media favor ABT or TSLA?

Which has stronger earnings & valuation, ABT or TSLA?

Which has more volatility and risk, ABT or TSLA?

Summary

How does Abbott Laboratories compare to AbbVie?

Is ABT or ABBV more profitable?

Is ABT or ABBV a better dividend stock?

Does the media refer more to ABT or ABBV?

Do institutionals and insiders believe in ABT or ABBV?

Do analysts recommend ABT or ABBV?

Which has more volatility and risk, ABT or ABBV?

Which has better earnings and valuation, ABT or ABBV?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Is ABT or BSX more profitable?

Do analysts rate ABT or BSX?

Does the media refer more to ABT or BSX?

Which has more volatility and risk, ABT or BSX?

Which has preferable earnings & valuation, ABT or BSX?

Do insiders and institutionals hold more shares of ABT or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools